1. Home
  2. SITM vs JAZZ Comparison

SITM vs JAZZ Comparison

Compare SITM & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SITM
  • JAZZ
  • Stock Information
  • Founded
  • SITM 2003
  • JAZZ 2003
  • Country
  • SITM United States
  • JAZZ Ireland
  • Employees
  • SITM N/A
  • JAZZ N/A
  • Industry
  • SITM Semiconductors
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • SITM Technology
  • JAZZ Health Care
  • Exchange
  • SITM Nasdaq
  • JAZZ Nasdaq
  • Market Cap
  • SITM 8.5B
  • JAZZ 8.6B
  • IPO Year
  • SITM 2019
  • JAZZ 2007
  • Fundamental
  • Price
  • SITM $277.87
  • JAZZ $180.71
  • Analyst Decision
  • SITM Strong Buy
  • JAZZ Strong Buy
  • Analyst Count
  • SITM 7
  • JAZZ 15
  • Target Price
  • SITM $312.14
  • JAZZ $194.40
  • AVG Volume (30 Days)
  • SITM 407.7K
  • JAZZ 1.5M
  • Earning Date
  • SITM 11-05-2025
  • JAZZ 11-05-2025
  • Dividend Yield
  • SITM N/A
  • JAZZ N/A
  • EPS Growth
  • SITM N/A
  • JAZZ N/A
  • EPS
  • SITM N/A
  • JAZZ N/A
  • Revenue
  • SITM $281,486,000.00
  • JAZZ $4,157,832,999.00
  • Revenue This Year
  • SITM $46.07
  • JAZZ $5.80
  • Revenue Next Year
  • SITM $27.48
  • JAZZ $6.06
  • P/E Ratio
  • SITM N/A
  • JAZZ N/A
  • Revenue Growth
  • SITM 59.04
  • JAZZ 4.14
  • 52 Week Low
  • SITM $105.40
  • JAZZ $95.49
  • 52 Week High
  • SITM $386.00
  • JAZZ $182.99
  • Technical
  • Relative Strength Index (RSI)
  • SITM 48.83
  • JAZZ 80.42
  • Support Level
  • SITM $243.68
  • JAZZ $128.80
  • Resistance Level
  • SITM $287.67
  • JAZZ $182.99
  • Average True Range (ATR)
  • SITM 24.62
  • JAZZ 6.74
  • MACD
  • SITM -3.64
  • JAZZ 4.24
  • Stochastic Oscillator
  • SITM 24.94
  • JAZZ 94.19

About SITM SiTime Corporation

SiTime Corp is a provider of silicon timing systems solutions. The company designs develops and sell silicon timing systems solutions for different industries including automotive, infrastructure, aerospace-defense, consumer, internet of things, consumer and industrials. Its product offerings include Stratum 3E DCOCXOs, Programmable OCXOs, MHz Oscillators, 32.768 kHz Oscillators, Embedded Resonators, Precision MHz Super-TCXOs, and Ruggedized Oscillators. It sells its products around Taiwan, Hong Kong, the United States, and other regions and generates the majority of its revenue from Taiwan.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: